The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits (Q33400837)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits |
scientific article |
Statements
1 reference
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits (English)
1 reference
Joanne Chiu
1 reference
Yuen Fong Tang
1 reference
Tzy-Jyun Yao
1 reference
Ashley Wong
1 reference
Hilda Wong
1 reference
Roland Leung
1 reference
Pierre Chan
1 reference
Tan To Cheung
1 reference
Albert C Chan
1 reference
Roberta Pang
1 reference
Sheung-Tat Fan
1 reference
Ronnie Poon
1 reference
19 April 2012
1 reference
1 reference
118
1 reference
21
1 reference
5293-5301
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference